المساهمون: Junhwan Kim, Joseph J Noh, Tae Kyoung Lee, Se Ik Kim, Jung-Yun Lee, Jeong-Won Lee, Jae-Weon Kim, Lee, Jung-Yun

مصطلحات موضوعية: Adult, Aged, Antibodies, Monoclonal, Humanized, Endometrial Neoplasms* / drug therapy, Female, Humans, Middle Aged, Neoplasm Recurrence, Local / drug therapy, Phenylurea Compounds / adverse effects, Quinolines* / adverse effects, Retrospective Studies, Endometrial neoplasm, Lenvatinib, Pembrolizumab, Prognosis, Toxicity, Treatment

العلاقة: GYNECOLOGIC ONCOLOGY; J00956; OAK-2022-06071; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191427Test; https://www.sciencedirect.com/science/article/pii/S0090825822001408?via%3DihubTest; T202205447; GYNECOLOGIC ONCOLOGY, Vol.165(2) : 369-375, 2022-05

الإتاحة: https://doi.org/10.1016/j.ygyno.2022.02.020Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191427Test
https://www.sciencedirect.com/science/article/pii/S0090825822001408?via%3DihubTest

المساهمون: Bo Hyun Kim, Su Jong Yu, Wonseok Kang, Sung Bum Cho, Soo Young Park, Seung Up Kim, Do Young Kim, Kim, Do Young

مصطلحات موضوعية: Carcinoma, Hepatocellular* / drug therapy, Consensus, Drug-Related Side Effects and Adverse Reactions* / therapy, Humans, Liver Neoplasms* / drug therapy, Phenylurea Compounds* / adverse effects, Protein Kinase Inhibitors / adverse effects, Quinolines* / adverse effects, adverse events, hepatocellular carcinoma, lenvatinib, management

العلاقة: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY; J01417; OAK-2022-02430; https://ir.ymlib.yonsei.ac.kr/handle/22282913/189289Test; T202202168; JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.37(3) : 428-439, 2022-03

الإتاحة: https://doi.org/10.1111/jgh.15727Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/189289Test

المساهمون: Takuji Okusaka, Kenji Ikeda, Masatoshi Kudo, Richard Finn, Shukui Qin, Kwang-Hyub Han, Ann-Lii Cheng, Fabio Piscaglia, Masahiro Kobayashi, Max Sung, Minshan Chen, Lucjan Wyrwicz, Jung-Hwan Yoon, Zhenggang Ren, Kalgi Mody, Corina Dutcus, Toshiyuki Tamai, Min Ren, Seiichi Hayato, Hiromitsu Kumada, Han, Kwang Hyup

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Agents / adverse effects, Antineoplastic Agents / pharmacology, Antineoplastic Agents / therapeutic use, Body Weight / drug effects, Carcinoma, Hepatocellular / drug therapy, Dose-Response Relationship, Drug, Female, Humans, Liver Neoplasms / complications, Liver Neoplasms / drug therapy, Male, Middle Aged, Phenylurea Compounds / adverse effects, Phenylurea Compounds / pharmacology, Phenylurea Compounds / therapeutic use, Quinolines / adverse effects, Quinolines / pharmacology, Quinolines / therapeutic use, Sorafenib / adverse effects, Sorafenib / pharmacology, Sorafenib / therapeutic use, Treatment Outcome, Body weight, Dosing, Hepatocellular carcinoma

العلاقة: JOURNAL OF GASTROENTEROLOGY; J01416; OAK-2022-04247; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190430Test; T202126062; JOURNAL OF GASTROENTEROLOGY, Vol.56(6) : 570-580, 2021-06

الإتاحة: https://doi.org/10.1007/s00535-021-01785-0Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190430Test

المساهمون: Robert Motzer, Boris Alekseev, Sun-Young Rha, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E Hutson, Evgeny Kopyltsov, María J Méndez-Vidal, Vadim Kozlov, Anna Alyasova, Sung-Hoo Hong, Anil Kapoor, Teresa Alonso Gordoa, Jaime R Merchan, Eric Winquist, Pablo Maroto, Jeffrey C Goh, Miso Kim, Howard Gurney, Vijay Patel, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Bohuslav Melichar, Frederic Rolland, Ugo De Giorgi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Corina E Dutcus, Alan D Smith, Lea Dutta, Kalgi Mody, Rodolfo F Perini, Dongyuan Xing, Toni K Choueiri, Rha, Sun Young

مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized / administration & dosage, Humanized / adverse effects, Antineoplastic Agents / adverse effects, Antineoplastic Agents / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Carcinoma, Renal Cell / drug therapy, Renal Cell / mortality, Everolimus / administration & dosage, Everolimus / adverse effects, Female, Humans, Kidney Neoplasms / drug therapy, Kidney Neoplasms / mortality, Male, Middle Aged, Phenylurea Compounds / administration & dosage, Phenylurea Compounds / adverse effects, Programmed Cell Death 1 Receptor / antagonists & inhibitors, Progression-Free Survival, Protein Kinase Inhibitors / therapeutic use, Quinolines / administration & dosage, Quinolines / adverse effects, Sunitinib / adverse effects

العلاقة: NEW ENGLAND JOURNAL OF MEDICINE; J02371; OAK-2021-06182; https://ir.ymlib.yonsei.ac.kr/handle/22282913/185460Test; T202104165; NEW ENGLAND JOURNAL OF MEDICINE, Vol.384(14) : 1289-1300, 2021-04

الإتاحة: https://doi.org/10.1056/NEJMoa2035716Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/185460Test

المؤلفون: Wick, Antje, Desjardins, Annick, Suarez, Cristina, Forsyth, Peter, Gueorguieva, Ivelina, Burkholder, Tiana, Cleverly, Ann Louise, Estrem, Shawn T., Wang, Shuaicheng, Lahn, Michael M., Guba, Susan C., Capper, David, Rodon, Jordi

المصدر: http://lobid.org/resources/99370674913906441Test#!, 38(5):1570-1579.

مصطلحات موضوعية: Biomarkers, Antineoplastic Agents/adverse effects [MeSH], Pyrazoles/adverse effects [MeSH], Aged [MeSH], Antineoplastic Agents/administration, Quinolines/adverse effects [MeSH], Male [MeSH], Glioma/immunology [MeSH], T cells, T-Lymphocyte Subsets/drug effects [MeSH], Glioma/therapy [MeSH], Protein Kinase Inhibitors/adverse effects [MeSH], Receptor, Transforming Growth Factor-beta Type I/antagonists, Female [MeSH], Glioma/metabolism [MeSH], Radiochemotherapy, Brain Neoplasms/immunology [MeSH], Humans [MeSH], Galunisertib, Protein Kinase Inhibitors/administration, Middle Aged [MeSH], Pyrazoles/administration, Antineoplastic Combined Chemotherapy Protocols/administration, Glioblastoma, Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Tumor/metabolism [MeSH], Phase II Studies, Temozolomide/administration, Quinolines/administration

العلاقة: https://repository.publisso.de/resource/frl:6468388Test; https://doi.org/10.1007/s10637-020-00910-9Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497674Test/

الإتاحة: https://doi.org/10.1007/s10637-020-00910-9Test
https://repository.publisso.de/resource/frl:6468388Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497674Test/

المؤلفون: Aydemirli, M D, Kapiteijn, E, Ferrier, K R M, Ottevanger, P B, Links, T P, van der Horst-Schrivers, A N A, Broekman, K E, Groenwold, R H H, Zwaveling, J

المصدر: Aydemirli , M D , Kapiteijn , E , Ferrier , K R M , Ottevanger , P B , Links , T P , van der Horst-Schrivers , A N A , Broekman , K E , Groenwold , R H H & Zwaveling , J 2020 , ' Effectiveness and toxicity of lenvatinib in refractory thyroid cancer : Dutch real-life data ' , European Journal of Endocrinology , vol. 182 , no. 2 , pp. 131-138 . https://doi.org/10.1530/EJE-19-0763Test

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Agents/therapeutic use, Disease-Free Survival, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Phenylurea Compounds/adverse effects, Quinolines/adverse effects, Retrospective Studies, Thyroid Neoplasms/drug therapy

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/95846c5d-1a76-4caa-926e-65a4053d0ad1Test

الإتاحة: https://doi.org/10.1530/EJE-19-0763Test
https://hdl.handle.net/11370/95846c5d-1a76-4caa-926e-65a4053d0ad1Test
https://research.rug.nl/en/publications/95846c5d-1a76-4caa-926e-65a4053d0ad1Test
https://pure.rug.nl/ws/files/116876227/Effectiveness_and_toxicity_of_lenvatinib_in_refractory_thyroid_cancer_Dutch_real_life_data.pdfTest

المؤلفون: VX18-445-104 Study Group, Barry, Peter J, Mall, Marcus A, Álvarez, Antonio, Colombo, Carla, de Winter-de Groot, Karin M, Fajac, Isabelle, McBennett, Kimberly A, McKone, Edward F, Ramsey, Bonnie W, Sutharsan, Sivagurunathan, Taylor-Cousar, Jennifer L, Tullis, Elizabeth, Ahluwalia, Neil, Jun, Lucy S, Moskowitz, Samuel M, Prieto-Centurion, Valentin, Tian, Simon, Waltz, David, Xuan, Fengjuan, Zhang, Yaohua, Rowe, Steven M, Polineni, Deepika, Vanderhelst, Eef, De Wachter, Elke

المساهمون: Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Physiotherapy, Human Physiology and Anatomy, Clinical sciences, Pneumology, Pediatrics

المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2021, 385 (9), pp.815-825. ⟨10.1056/NEJMoa2100665⟩
N Engl J Med

مصطلحات موضوعية: Male, [SDV]Life Sciences [q-bio], Medizin, Gating, Cystic fibrosis, Gastroenterology, 0302 clinical medicine, Genotype, 030212 general & internal medicine, Child, biology, General Medicine, respiratory system, Cystic fibrosis transmembrane conductance regulator, 3. Good health, Drug Combinations, Chlorides/analysis, Indoles/adverse effects, Female, Benzodioxoles/adverse effects, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, 2019-20 coronavirus outbreak, congenital, hereditary, and neonatal diseases and abnormalities, Adolescent, Chloride Channel Agonists/adverse effects, Aminophenols/adverse effects, Sweat/chemistry, Article, 03 medical and health sciences, Double-Blind Method, Pyrazoles/adverse effects, Internal medicine, medicine, Humans, In patient, Pyridines/adverse effects, Quinolines/adverse effects, business.industry, medicine.disease, respiratory tract diseases, Regimen, 030228 respiratory system, biology.protein, Cystic Fibrosis Transmembrane Conductance Regulator/genetics, Cystic Fibrosis/drug therapy, business, Function (biology)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d49a389d697896fcc9784fdccd67e9eTest
https://hal.archives-ouvertes.fr/hal-03328264Test

المؤلفون: Motzer, Robert, Alekseev, Boris, Rha, Sun-Young, Porta, Camillo, Eto, Masatoshi, Powles, Thomas, Grünwald, Viktor, Hutson, Thomas E, Kopyltsov, Evgeny, Méndez-Vidal, María J, Kozlov, Vadim, Alyasova, Anna, Hong, Sung-Hoo, Kapoor, Anil, Alonso Gordoa, Teresa, Merchan, Jaime R, Winquist, Eric, Maroto, Pablo, Goh, Jeffrey C, Kim, Miso, Gurney, Howard, Patel, Vijay, Peer, Avivit, Procopio, Giuseppe, Takagi, Toshio, Melichar, Bohuslav, Rolland, Frederic, De Giorgi, Ugo, Wong, Shirley, Bedke, Jens, Schmidinger, Manuela, Dutcus, Corina E, Smith, Alan D, Dutta, Lea, Mody, Kalgi, Perini, Rodolfo F, Xing, Dongyuan, Choueiri, Toni K, CLEAR Trial Investigators

المساهمون: Gennigens, Christine

المصدر: New England Journal of Medicine, 384 (14), 1289 - 1300 (2021-04-08)

مصطلحات موضوعية: Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Phenylurea Compounds, Programmed Cell Death 1 Receptor, Protein Kinase Inhibitors, Quinolines, Everolimus, pembrolizumab, lenvatinib, Sunitinib, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized/administration & dosage, Antibodies, Monoclonal, Humanized/adverse effects, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Renal Cell/drug therapy, Carcinoma, Renal Cell/mortality, Everolimus/administration & dosage, Everolimus/adverse effects, Female, Humans, Kidney Neoplasms/drug therapy, Kidney Neoplasms/mortality, Male, Middle Aged, Phenylurea Compounds/administration & dosage, Phenylurea Compounds/adverse effects, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Progression-Free Survival, Protein Kinase Inhibitors/therapeutic use, Quinolines/administration & dosage, Quinolines/adverse effects, Sunitinib/adverse effects, Sunitinib/therapeutic use, Survival Analysis, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Renal Cell, Kidney Neoplasms, Medicine (all), General Medicine, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie

العلاقة: http://www.nejm.org/doi/pdf/10.1056/NEJMoa2035716Test; urn:issn:0028-4793; urn:issn:1533-4406

الوصول الحر: https://orbi.uliege.be/handle/2268/300816Test

المساهمون: Dae Suk Kim, Jung Min Bae, Hyunjoong Jee, Hemin Lee, Do-Young Kim, Soo Min Kim, Min-Geol Lee, Kim, Dae Suk, Kim, Do Young, Bae, Jung Min, Lee, Min Geol

المصدر: T201400859.pdf

مصطلحات موضوعية: Naphthylamine/adverse effects, 2-Naphthylamine/analogs & derivatives, Adult, Asian Continental Ancestry Group, Cobalt/adverse effects, Dermatitis, Allergic Contact/etiology, Female, Humans, Hydrocortisone/adverse effects, Hydrocortisone/analogs & derivatives, Male, Mercury/adverse effects, Multiple Chemical Sensitivity/etiology, Neomycin/adverse effects, Nickel/adverse effects, Patch Tests, Phenylenediamines/adverse effects, Pilot Projects, Potassium Dichromate/adverse effects, Quinolines/adverse effects, Republic of Korea, Sulfhydryl Compounds/adverse effects, Thiram/adverse effects

وصف الملف: 80~81

العلاقة: ACTA DERMATO-VENEREOLOGICA; J00012; OAK-2014-00506; https://ir.ymlib.yonsei.ac.kr/handle/22282913/98426Test; T201400859; ACTA DERMATO-VENEREOLOGICA, Vol.94(1) : 80-81, 2014

الإتاحة: https://doi.org/10.2340/00015555-1649Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/98426Test

المؤلفون: A. N. A. van der Horst-Schrivers, Ellen Kapiteijn, K R M Ferrier, M D Aydemirli, Juliette Zwaveling, Thera P. Links, Rolf H.H. Groenwold, K E Broekman, Petronella B. Ottevanger

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE)

المصدر: European Journal of Endocrinology, 182, 2, pp. 131-138
European Journal of Endocrinology, 182, 131-138
European Journal of Endocrinology, 182(2), 131-138. BIOSCIENTIFICA LTD

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Population, Gallbladder disease, 030209 endocrinology & metabolism, Antineoplastic Agents, Kaplan-Meier Estimate, Disease-Free Survival, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, All institutes and research themes of the Radboud University Medical Center, Internal medicine, 80 and over, Medicine, Humans, Thyroid Neoplasms, education, Phenylurea Compounds/adverse effects, Thyroid cancer, Aged, Quinolines/adverse effects, Retrospective Studies, Response rate (survey), Aged, 80 and over, education.field_of_study, business.industry, Phenylurea Compounds, Antineoplastic Agents/therapeutic use, Retrospective cohort study, General Medicine, Middle Aged, medicine.disease, Confidence interval, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], chemistry, 030220 oncology & carcinogenesis, Quinolines, Population study, Female, Thyroid Neoplasms/drug therapy, business, Lenvatinib

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea8fffdedc9c6ce4b7c6c85c755def11Test
https://hdl.handle.net/2066/216644Test